Follow-on offering Announced
Liminatus Pharma equity raising
US$4m raised
Announced 17 Feb 2026 · NASDAQ: LIMN
Advisers
Lead managers
- Legal adviser
- Placement agent
- Issuer
- Liminatus Pharma
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Cell Therapy, Oncology
Similar deals
- Chimeric Therapeutics placement (May 2025) May 2025 · US$4.2m · Biotech
- Obsidian Therapeutics placement Apr 2026 · US$350m · Biotech
- Silexion Therapeutics Corp equity raising US$2.5m · Biotech
- Imugene placement (March 2026) Mar 2026 · US$14m · Biotech
- AdAlta placement (January 2026) Jan 2026 · US$841,296 · Biotech
Sources
- 18 Feb 2026 Final IPO prospectus (424B4), Liminatus Pharma, Inc. sec.gov